InvestorsHub Logo
Post# of 252493
Next 10
Followers 31
Posts 1184
Boards Moderated 0
Alias Born 08/23/2004

Re: projectchris post# 120859

Wednesday, 06/01/2011 9:14:55 PM

Wednesday, June 01, 2011 9:14:55 PM

Post# of 252493
Lymphoseek will likely get A-code radiopharmaceutical reimbursement. Private payers still pay for A-code's. Granted, medicare recently only started paying bundles exam type only in the name of health care reform. That said, sulfur colloid doesn't have a designated specific A-code reimbursement.

I believe medicare only pays A-code to I-123 and or I-131 radiopharmaceuticals. I don't think lymphoseek will be an exception to this medicare rule, but will have to find out.

The financial aspect depends on your medicare vs private payer population. You could probably recoup approx. $340 reimbursement of that $200 lymphoseek price tag on lymphoseek with the likely A-code private payer reimbursement


In south florida most managed care pay between 50% (on the low end) of Medicare to 105%. Most are in the 80-95%. In texas and the midwest the reimbursement is much better. Most insurance companies follow medicare on reimbursing items, especially if it will save them money. They can use the cover that the government doesn't pay for that why should we?

We have very little private insurance.

If NEOP can creep back over 5$ I will likely short it if my broker can still get a borrow.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.